In healthcare, good decisions depend on good data, but great decisions depend on the right insights. For brand managers, marketers and strategists, primary market research provides the missing link between numbers and nuance.
Primary market research goes straight to the source, gathering key insights from real consumers, customers and your target audience to understand their needs, preferences, behaviours and reactions. This can be through surveys and questionnaires, interviews, focus groups and product observations.
At M3, we’ve seen firsthand how the right research – fast, focused, and fit for purpose – can turn confusion into clarity, course-correct a launch or reshape how a message lands with clinicians. Here’s why it matters and how it drives measurable outcomes.
Why brand managers need primary market research
Brand Tracking
Sales data tells you what happened but not why. A dip or rise in sales could stem from dozens of underlying factors, such as lack of awareness, poor experience, mistrust or a single competitor gaining traction.
Primary market research gets you upstream of those numbers. It reveals the why behind the what. Do healthcare professionals actually know your brand? Do they trust you? Are there lingering efficacy or safety concerns holding them back? Or are you simply being out-messaged by a competitor?
This is especially critical at launch, when brand trajectory is set early and course corrections need to happen fast. Primary market research provides the real-time data that gives brand teams a chance to pivot before the sales reports are already out of date.
The ability to work smarter, not harder becomes easier with brand tracking through primary market research. This means you’re managing momentum, not just measuring outcomes.
Customer Segmentation
Everyone talks about “targeting” but few have the data to prove that their targeting actually works, especially in healthcare and pharma marketing. Outside of the industry, marketing effectiveness stats can be thin and outdated. Within the industry, stats to measure marketing effectiveness can be even thinner.
This is where a persona-led campaign can really help provide evidence-based targeting data. Campaigns aligned to well-researched audience personas perform better than those that use generic segmentation. In a recent M3 study, persona targeting encouraged deeper engagement, maximising click-through rates, with total average time spent increasing by 2 minutes and 9 seconds from each of the persona promoted pages combined. One page even saw campaign visits go from 1,000 to nearly 9,800 after persona targeting was introduced.
Primary market research helps define these personas by going beyond demographics, delving into mindset, motivations and barriers to behaviour. That means marketing that reaches the right audience with the right message, improving impact without increasing spend in the process.
With greater customer segmentation you are able to do more with less. Smarter segmentation means every message counts, fewer wasted impressions and the campaign engages more meaningfully with healthcare professionals, fostering greater results.
Understanding what drives decisions
In our own clinician interviews, one message came through loud and clear: healthcare professionals are inundated with content that feels irrelevant or repetitive. As one clinician put it: “Someone hasn’t thought this through.”
This is where primary market research earns its keep. By talking directly to clinicians, you can uncover what truly matters – the real differentiators, not just perceived USPs. Once you have this, storytelling becomes sharper, messages more resonant and campaigns more credible.
It is not about throwing more information at clinicians, it’s about cutting through the noise with messages that speak to their priorities, pain points and realities. Primary market research helps you stop guessing and start knowing what matters to your audience so your story actually lands.
Context is key
Healthcare budgets in the UK aren’t growing anytime soon. According to the Association of the British Pharmaceutical Industry (ABPI), the UK is losing ground in global pharma R&D investment, with growth at around 1.9% per year since 2018, compared to global average of around 6.6%. Doing more with less is becoming an operational reality. In this environment, research often gets unfairly labelled a “nice-to-have” or a “cost centre.”
However, primary market research needs to be viewed correctly – it is an investment not a necessary evil. Every insight helps focus resources on what works and stop spending on what doesn’t. That’s not a luxury, that’s efficiency.
In short, primary market research enables you to:
- Validate which channels truly drive engagement
- Identify friction points before they impact prescribing
- Measure the ROI of communications with real clinician feedback
Insight isn’t a cost, it’s clarity – and clarity brings more bang for your buck.
The Bigger Picture
For us at M3, primary market research isn’t just about understanding the market; it’s about improving healthcare outcomes.
When you know what drives clinicians’ decisions, you can tailor education, engagement and access strategies that ultimately improve patient care. When you understand patient perceptions, you can shape messaging that promotes adherence and trust.
Combining primary market research with a coherent and strong digital reach and clinician community, you can move faster with data to decisions to real-world impact.
Final Thoughts
In a world where healthcare teams are stretched and budgets are flat, the brands that win will be those that understand their audiences the best,, not those who just shout the loudest. Primary market research bridges the gap between assumptions and insights. It turns noise into knowledge, bringing more certainty and proof to campaigns strategy. From this, clarity can be instilled to form sharper campaigns, razor-sharp focus and, in turn, better results with increased ROI and relationships that foster greater rewards.
Primary market research brings brands, clinicians and patients together to mould fully developed campaigns that are committed to better decisions and better healthcare outcomes.
